FDA Inspection 682976 — Center for Reproductive Health and Gynecology

Center for Reproductive Health and Gynecology — FEI 3004627513

The FDA completed an inspection of Center for Reproductive Health and Gynecology on September 24, 2010 in Beverly Hills, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 24, 2010
Fiscal Year
2010
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Beverly Hills, CA (United States)